# US 2002/0160419 A1 · Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0160419 A1
- Document ID: US20020160419A1
- Status: Published application
- Kind: A1
- Application number: 09/845,739
- Filed: 2001-04-30
- Published: 2002-10-31
- Earliest claimed: 2001-04-30
- Assignees: Syn X Pharma, Inc.
- Inventors: George Jackowski; Brad Thatcher; John Marshall; Jason Yantha; Tammy Vrees
- Web page: https://patentgrep.com/patent/US20020160419A1

## CPC

- G01N 33/6893: {related to diseases not provided for elsewhere}
- Y10S 436/811: Test for named disease, body condition or organ function
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

## Claims

### Claim 1

A biopolymer marker having the sequence ID SKITHRIHWESASLL useful in indicating at least one particular disease state.

### Claim 2 (depends on 1)

The biopolymer marker of claim 1 wherein said disease state is congestive heart failure.
